{"id":"W2300122958","doi":"10.1200/jco.2005.23.16_suppl.4611","title":"First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer (HRPC): Does sequence matter?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Docetaxel; Mitoxantrone; Medicine; Internal medicine; Chemotherapy; Oncology; Regimen; Prostate cancer; Performance status; Progression-free survival; Surgery; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008643854,0.00008491835,0.0004391052,0.0003338646,0.000360591,0.0004881947,0.0002746418,0.000328029,0.001283572],"category_scores_gemma":[0.0037462,0.0001051218,0.0003230651,0.0007671561,0.0002323022,0.000214162,0.0002039255,0.0004042309,0.0001164234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001710912,"about_ca_system_score_gemma":0.003274207,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04747636,"about_ca_topic_score_gemma":0.1313114,"domain_scores_codex":[0.9995078,0.0001584909,0.00005295517,0.00006739506,0.000138577,0.00007482198],"domain_scores_gemma":[0.9980609,0.0005604249,0.0008972251,0.00004840051,0.000152342,0.0002807632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.005138436,0.0001645652,0.9583453,0.0001940354,0.000143529,0.0002784347,0.0001359552,0.0002069317,0.0004463365,0.00004519025,0.0005084611,0.0343928],"study_design_scores_gemma":[0.0004022454,0.002219455,0.9934167,0.0001416499,0.000246391,0.0009975914,0.0002988131,0.0007433115,0.0001900339,0.0001147227,0.001220717,0.000008467304],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920637,0.005976057,0.00006231022,0.0004738409,0.00001649042,0.00004292697,0.0001840118,0.000003215,0.001177381],"genre_scores_gemma":[0.99835,0.001179477,0.00006674117,0.0001131366,0.00001627972,0.000008278935,0.0001389589,0.000001132319,0.0001260934],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04747636,"threshold_uncertainty_score":0.09439999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04831283444831135,"score_gpt":0.4267512080186877,"score_spread":0.3784383735703763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}